Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  03/23/2012
 
Trade Name:  QNASL
 
Generic or Proper Name (*):  QNASL beclomethasone dipropionate
 
Indications Studied:  Treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis
 
Therapeutic Category:  Anti-inflammatory, topical
 
Ages Studied:  12-17 years
 
Study #:  4
 
Study Type:  Efficacy/Safety/Tolerability
 
Study Design:  Blind/Placebo/Parallel Group
 
No Patients:  55
 
No Centers:  36
 
No Countries:  1P
 
-
-